Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Tortoise Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of May 31, 2019 for TYG, NTG, TTP, NDP, TPZ and TEAF

Published

on

Reading Time: 7 minutes

LEAWOOD, Kan.–(BUSINESS WIRE)–Tortoise today announced the following unaudited balance sheet
information and asset coverage ratio updates for TYG, NTG, TTP, NDP, TPZ
and TEAF.

Tortoise Energy Infrastructure Corp. (NYSE: TYG) today announced
that as of May 31, 2019, the company’s unaudited total assets were
approximately $2.1 billion and its unaudited net asset value was $1.2
billion, or $22.76 per share.

As of May 31, 2019, the company was in compliance with its asset
coverage ratios under the Investment Company Act of 1940 (the 1940 Act)
and basic maintenance covenants. The company’s asset coverage ratio
under the 1940 Act with respect to senior securities representing
indebtedness was 367 percent, and its coverage ratio for preferred
shares was 279 percent. For more information on calculation of coverage
ratios, please refer to the company’s most recent applicable prospectus.

Set forth below is a summary of the company’s preliminary unaudited
balance sheet at May 31, 2019.

Preliminary Unaudited balance sheet

                         
(in Millions) Per Share
Investments $ 2,090.3 $ 38.97
Cash and Cash Equivalents 0.3 0.01
Current Tax Asset 15.6 0.29
Other Assets   4.3   0.08
Total Assets   2,110.5   39.35
 
Credit Facility Borrowings 138.7 2.59
Senior Notes 380.0 7.08
Preferred Stock   165.0   3.08
Total Leverage   683.7   12.75
 
Payable for Investments Purchased 0.9 0.02
Other Liabilities 12.4 0.23
Deferred Tax Liability   192.6   3.59
Net Assets $ 1,220.9 $ 22.76
 

53.64 million common shares currently outstanding.

 

Tortoise Midstream Energy Fund, Inc. (NYSE: NTG) today announced
that as of May 31, 2019, the company’s unaudited total assets were
approximately $1.5 billion and its unaudited net asset value was $886.3
million, or $14.02 per share.

As of May 31, 2019, the company was in compliance with its asset
coverage ratios under the Investment Company Act of 1940 (the 1940 Act)
and basic maintenance covenants. The company’s asset coverage ratio
under the 1940 Act with respect to senior securities representing
indebtedness was 358 percent, and its coverage ratio for preferred
shares was 268 percent. For more information on calculation of coverage
ratios, please refer to the company’s most recent applicable prospectus.

Set forth below is a summary of the company’s preliminary unaudited
balance sheet at May 31, 2019.

Preliminary Unaudited balance sheet

                         
(in Millions) Per Share
Investments $ 1,494.9 $ 23.65
Cash and Cash Equivalents 0.3 0.00
Current Tax Asset 1.9 0.03
Other Assets   1.2   0.02
Total Assets   1,498.3   23.70
 
Credit Facility Borrowings 83.3 1.32
Senior Notes 312.0 4.93
Preferred Stock   132.0   2.09
Total Leverage   527.3   8.34
 
Other Liabilities 7.0 0.11
Deferred Tax Liability   77.7   1.23
Net Assets $ 886.3 $ 14.02
 

63.21 million common shares currently outstanding.

 

Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today
announced that as of May 31, 2019, the company’s unaudited total assets
were approximately $222.7 million and its unaudited net asset value was
$157.1 million, or $15.68 per share.

As of May 31, 2019, the company was in compliance with its asset
coverage ratios under the Investment Company Act of 1940 (the 1940 Act)
and basic maintenance covenants. The company’s asset coverage ratio
under the 1940 Act with respect to senior securities representing
indebtedness was 467 percent, and its coverage ratio for preferred
shares was 349 percent. For more information on calculation of coverage
ratios, please refer to the company’s most recent applicable prospectus.

Set forth below is a summary of the company’s preliminary unaudited
balance sheet at May 31, 2019.

Preliminary Unaudited balance sheet

                         
(in Millions) Per Share
Investments $ 220.9 $ 22.05
Cash and Cash Equivalents 0.2 0.02
Receivable for Investments Sold 1.0 0.10
Other Assets   0.6   0.06
Total Assets   222.7   22.23
 
Credit Facility Borrowings 13.1 1.31
Senior Notes 34.0 3.39
Preferred Stock   16.0   1.60
Total Leverage   63.1   6.30
 
 
Payable for Investments Purchased 1.2 0.12
Other Liabilities   1.3   0.13
Net Assets $ 157.1 $ 15.68
 

10.02 million common shares currently outstanding.

 

Tortoise Energy Independence Fund, Inc. (NYSE: NDP) today
announced that as of May 31, 2019, the company’s unaudited total assets
were approximately $123.2 million and its unaudited net asset value was
$87.7 million, or $5.94 per share.

As of May 31, 2019, the company was in compliance with its asset
coverage ratios under the Investment Company Act of 1940 (the 1940 Act).
The company’s asset coverage ratio under the 1940 Act with respect to
senior securities representing indebtedness was 354 percent. For more
information on calculation of coverage ratios, please refer to the
company’s most recent applicable prospectus.

Set forth below is a summary of the company’s preliminary unaudited
balance sheet at May 31, 2019.

Preliminary Unaudited balance sheet

                         
(in Millions) Per Share
Investments $ 122.8 $ 8.31
Cash and Cash Equivalents 0.3 0.02
Other Assets   0.1   0.01
Total Assets   123.2   8.34
 
Credit Facility Borrowings 34.6 2.34
 
Other Liabilities   0.9   0.06
Net Assets $ 87.7 $ 5.94
 

14.77 million common shares currently outstanding.

 

Tortoise Power and Energy Infrastructure Fund, Inc. (NYSE: TPZ)
today announced that as of May 31, 2019, the company’s unaudited total
assets were approximately $197.7 million and its unaudited net asset
value was $139.8 million, or $20.11 per share.

As of May 31, 2019, the company was in compliance with its asset
coverage ratios under the Investment Company Act of 1940 (the 1940 Act).
The company’s asset coverage ratio under the 1940 Act with respect to
senior securities representing indebtedness was 347 percent. For more
information on calculation of coverage ratios, please refer to the
company’s most recent applicable prospectus.

Set forth below is a summary of the company’s preliminary unaudited
balance sheet at May 31, 2019.

Preliminary Unaudited balance sheet

                         
(in Millions) Per Share
Investments $ 195.0 $ 28.06
Cash and Cash Equivalents 0.2 0.03
Receivable for Investments Sold 0.7 0.09
Other Assets   1.8   0.26
Total Assets   197.7   28.44
 
Credit Facility Borrowings 56.6 8.14
 
Payable for Investments Purchased 0.5 0.07
Other Liabilities   0.8   0.12
Net Assets $ 139.8 $ 20.11
 

6.95 million common shares currently outstanding.

 

Tortoise Essential Assets Income Term Fund (NYSE: TEAF) today
announced that as of May 31, 2019, the company’s unaudited total assets
were approximately $288.0 million and its unaudited net asset value was
$255.5 million, or $18.94 per share.

As of May 31, 2019, the company was in compliance with its asset
coverage ratios under the Investment Company Act of 1940 (the 1940 Act).
For more information on calculation of coverage ratios, please refer to
the company’s most recent applicable prospectus.

Set forth below is a summary of the company’s preliminary unaudited
balance sheet at May 31, 2019.

Preliminary Unaudited balance sheet

                         
(in Millions) Per Share
Investments $ 285.3 $ 21.15
Cash and Cash Equivalents 0.7 0.05
Other Assets   2.0   0.15
Total Assets   288.0   21.35
 
Credit Facility Borrowings 31.5 2.33
 
Other Liabilities   1.0   0.08
Net Assets $ 255.5 $ 18.94
 

13.49 million common shares currently outstanding.

 

The top 10 holdings for TYG, NTG, TTP, NDP and TPZ as of the most recent
month-end can be found on each fund’s portfolio web page at https://cef.tortoiseadvisors.com.

Essential Assets Conference Call

Tortoise will host a conference call on July 24, 2019 at 3 p.m. Central
to discuss the essential asset sectors and provide an update on
Tortoise’s outlook.

Toll Free Dial-In Number: (877) 407-9210
Replay Number: (877)
481-4010
Replay ID: #41354 (available through Aug. 24, 2019)

About Tortoise Energy Infrastructure Corp.

Tortoise Energy Infrastructure Corp. (NYSE: TYG) owns a portfolio of
master limited partnership investments in the energy infrastructure
sector. Tortoise Energy Infrastructure Corp.’s objective is to provide
its stockholders a high level of total return with an emphasis on
current distributions.

About Tortoise Midstream Energy Fund, Inc.

Tortoise Midstream Energy Fund, Inc. (NYSE: NTG) owns a portfolio of
midstream energy entities that own and operate a network of pipeline and
energy-related logistical infrastructure assets with an emphasis on
those that transport, gather, process and store natural gas and natural
gas liquids (NGLs). Tortoise Midstream Energy Fund, Inc.’s objective is
to provide its stockholders a high level of total return with an
emphasis on current distributions.

About Tortoise Pipeline & Energy Fund, Inc.

Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) is a non-diversified,
closed-end management investment company that seeks to obtain a high
level of total return with an emphasis on current distributions. TTP
invests primarily in equity securities of pipeline companies that
transport natural gas, natural gas liquids (NGLs), crude oil and refined
products and, to a lesser extent, in other energy infrastructure
companies.

About Tortoise Energy Independence Fund, Inc.

Tortoise Energy Independence Fund, Inc. (NYSE: NDP) is a
non-diversified, closed-end management investment company that seeks to
obtain a high level of total return with an emphasis on current
distributions. NDP invests primarily in North American energy companies
that engage in the exploration and production of crude oil, condensate,
natural gas and natural gas liquids.

About Tortoise Power and Energy Infrastructure Fund, Inc.

Tortoise Power and Energy Infrastructure Fund, Inc. (NYSE: TPZ) invests
in a portfolio of fixed income and equity securities issued by power and
energy infrastructure companies. TPZ’s objective is to provide
stockholders a high level of current income, with a secondary objective
of capital appreciation.

About Tortoise Essential Assets Income Term Fund

Tortoise Essential Assets Income Term Fund (NYSE: TEAF) is a
non-diversified, closed-end management investment company that seeks to
provide a high level of total return with an emphasis on current
distributions. TEAF provides investors access to a combination of public
and direct investments in essential assets that are making an impact on
clients and communities.

About Tortoise

Tortoise invests in essential assets – those assets and services that
are indispensable to the economy and society. With a steady wins
approach and a long-term perspective, Tortoise strives to make a
positive impact on clients and communities. For additional information,
please visit tortoiseadvisors.com.

Tortoise Capital Advisors, LLC is the Adviser to Tortoise Energy
Infrastructure Corp., Tortoise Midstream Energy Fund, Inc., Tortoise
Pipeline & Energy Fund, Inc., Tortoise Energy Independence Fund, Inc.,
Tortoise Power and Energy Infrastructure Fund, Inc. and Tortoise
Essential Assets Income Term Fund. Tortoise Credit Strategies, LLC and
Tortoise Advisors UK Limited are subadvisors to Tortoise Essential
Assets Income Term Fund.

Safe harbor statement

This press release shall not constitute an offer to sell or a
solicitation to buy, nor shall there be any sale of these securities in
any state or jurisdiction in which such offer or solicitation or sale
would be unlawful prior to registration or qualification under the laws
of such state or jurisdiction.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains certain statements that may include
“forward-looking statements” within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. All statements, other than statements of historical fact, included
herein are “forward-looking statements.” Although the funds and Tortoise
Capital Advisors believe that the expectations reflected in these
forward-looking statements are reasonable, they do involve assumptions,
risks and uncertainties, and these expectations may prove to be
incorrect. Actual results could differ materially from those anticipated
in these forward-looking statements as a result of a variety of factors,
including those discussed in the fund’s reports that are filed with the
Securities and Exchange Commission. You should not place undue reliance
on these forward-looking statements, which speak only as of the date of
this press release. Other than as required by law, the funds and
Tortoise Capital Advisors do not assume a duty to update this
forward-looking statement.

Contacts

Tortoise
Pam Kearney, Investor and Public Relations
(866)
362-9331
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

SCHWAZZE

Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results

Published

on

schwazze-announces-fourth-quarter-and-full-year-2023-financial-results

 FY 2023 Revenue of $172.4 Million; Income from Operations of $3.3 Million; Adjusted EBITDA of $53.4 Million or 31% of Revenue

 Generated $12.2 Million of Operating Cash Flow in FY 2023

DENVER, March 27, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the fourth quarter and full year ended December 31, 2023.

“This past year, the Schwazze team delivered solid top-line growth in two highly competitive markets with 31% adjusted EBITDA margins and improved operating cash flow,” said Forrest Hoffmaster, Interim CEO of Schwazze. “We continued to sharpen our retail strategy while expanding our store footprint by more than 50% to 63 dispensaries across our two markets. Although the Colorado and New Mexico markets were pressured in 2023, we have built a solid foundation with best-in-class service for our patients and customers. Internally, we are also relentlessly focused on maximizing the operating efficiencies of our manufacturing and cultivation facilities to drive higher yields, improved flower quality, and greater output.”

“With strong demand and over 680 recreational retail stores at year-end, the competitive landscape in Colorado is fierce, underscoring the importance of our investments in and attention to elevating the customer experience. We significantly outpaced the market in Q4 on a sequential and year-over-year basis and expect to bolster our growth through improvements in customer acquisition, retention, and loyalty, as well as in the overall retail experience. Additionally, we are beginning to see wholesale pricing stabilize, which we anticipate will continue based on plant counts and ongoing retail pricing pressure.”

“In New Mexico, the proliferation of new licenses has led to increased competition and aggressive pricing strategies from certain players. Cannabis sales in the state were up 18% across a store base that was over 50% higher year-over-year in Q4, leading to lower average revenue per store. While we are beginning to see a slow-down in net new store openings, we anticipate a challenging market ahead. We remain focused on cost optimization and asset utilization while implementing a balanced pricing and promotional strategy to drive traffic into our stores, where we believe we excel in delivering an elevated retail experience. We are committed to fulfilling our promise of being the retailer of choice in New Mexico.”

“Looking ahead, we are optimistic about the regulatory momentum in the industry at large. In the meantime, we will continue to elevate the customer experience, improve our loyalty program, increase our cost efficiencies, and enhance our retail assets. Our team has a demonstrated track record of executing in competitive markets like Colorado and New Mexico where we remain one of the largest operators. We look forward to driving growth and profitability across each of our markets in 2024.”

Fourth Quarter 2023 Financial Summary

$ in Thousands USD

Q4 2023

Q3 2023

Q4 2022

Total Revenue

$43,325

$46,747

$40,147

Gross Profit

$7,034

$21,438

$21,719

Adjusted Gross Profit[1]

$20,180

$21,438

$21,719

Operating Expenses

$23,276

$12,514

$24,224

Income (Loss) from Operations

$(16,242)

$8,924

$(2,505)

Adjusted EBITDA[2]

$10,953

$14,119

$13,285

Operating Cash Flow

$3,452

$6,946

$6,260

Full Year 2023 Financial Summary

$ in Thousands USD

FY 2023

FY 2022

Total Revenue

$172,448

$159,379

Gross Profit

$76,024

$80,289

Adjusted Gross Profit1

$89,170

$86,830

Operating Expenses

$72,735

$67,434

Income from Operations

$3,289

$12,855

Adjusted EBITDA2

$53,412

$52,010

Operating Cash Flow

$12,201

$6,694

___________________________

1  Adjusted Gross Profit is a non-GAAP measure as defined by the SEC and represents gross profit excluding non-cash inventory adjustments. The Company uses Adjusted Gross Profit as it believes it better explains the results of its core business. See “ADJUSTED GROSS PROFIT RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.

2  Adjusted EBITDA is a non-GAAP measure as defined by the SEC, and represents earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. The Company uses Adjusted EBITDA as it believes it better explains the results of its core business. See “ADJUSTED EBITDA RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.

Full Year 2023 Operational Highlights

  • Expanded the Company’s retail footprint by more than 50% in New Mexico and Colorado to 63 dispensaries.
  • Completed the acquisition of Everest Apothecary, adding 14 dispensaries, one cultivation facility, and one manufacturing plant to the Company’s New Mexico operations.
  • Acquired Standing Akimbo, the largest medical cannabis dispensary in Colorado, and opened the Company’s first medical dispensary in Colorado Springs under the Standing Akimbo banner.
  • Acquired two Colorado retail dispensaries in Fort Collins and Garden City from Smokey’s.
  • Unveiled an enhanced, custom ecommerce platform in New Mexico under the R. Greenleaf banner.
  • Increased wholesale penetration in Colorado and New Mexico by over 3x year-over-year to more than 27% total door penetration in both states.
  • Grew Lowell Farms pre-roll sales by over 250% in Colorado where it is now the #1 pre-roll in the state. In addition, Lowell is in six of the largest Colorado accounts and will be available for wholesale in New Mexico starting April 1st, 2024.
  • Grew sales with Wana, our fan-favorite gummies brand, by 48% in New Mexico where it is now in 130 doors with eight of the top ten accounts in the state.

Fourth Quarter 2023 Financial Results

Total revenue in the fourth quarter of 2023 increased 8% to $43.3 million compared to $40.1 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period and increased wholesale revenue, partially offset by pricing pressure from the proliferation of new licenses in New Mexico.

Gross profit for the fourth quarter of 2023 was $7.0 million or 16.2% of total revenue, compared to $21.7 million or 54.1% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. Adjusted gross profit, which excludes non-cash inventory adjustments, for the fourth quarter of 2023 was $20.2 million or 46.6% of revenue.

Operating expenses for the fourth quarter of 2023 were $23.3 million compared to $24.2 million for the same quarter last year. The decrease was primarily due to a lower impairment charge in the fourth quarter of 2023. This was partially offset by an increase in four-wall SG&A expenses associated with the 22 additional stores in Colorado and New Mexico that are still ramping, as well as greater salaries and stock-based compensation.

Loss from operations for the fourth quarter of 2023 was $16.2 million compared to $2.5 million in the same quarter last year. The decrease was driven by the aforementioned lower gross profit, primarily related to the non-cash inventory adjustment. Net loss was $33.9 million for the fourth quarter of 2023 compared to $27.3 million for the same quarter last year.

Adjusted EBITDA for the fourth quarter of 2023 was $11.0 million or 25.3% of revenue, compared to $13.3 million or 33.1% of revenue for the same quarter last year. The decrease in Adjusted EBITDA margin was primarily driven by higher operating expenses associated with the 22 additional stores that are still ramping.

As of December 31, 2023, cash and cash equivalents were $19.2 million compared to $38.9 million on December 31, 2022. Total debt as of December 31, 2023, was $156.8 million compared to $127.8 million on December 31, 2022.

Conference Call

The Company will conduct a conference call today, March 27, 2024, at 5:00 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2023.

Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].

Date: Wednesday, March 27, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 38840334
Webcast: SHWZ Q4 & FY 2023 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 840334

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS)
For the Periods Ended December 31, 2023 and 2022
Expressed in U.S. Dollars

For the Three Months Ended

For the Twelve Months Ended

December 31,

December 31,

2023

2022

2023

2022

(Unaudited)

(Unaudited)

(Audited)

(Audited)

Operating Revenues

Retail

$

39,592,779

$

36,868,429

$

155,463,816

$

141,254,893

Wholesale

3,730,749

3,158,670

16,765,425

17,819,938

Other

1,287

120,188

218,545

304,388

Total Revenue

43,324,815

40,147,287

172,447,786

159,379,219

Total Cost of Goods & Services

36,291,059

18,428,528

96,424,150

79,090,461

Gross Profit

7,033,756

21,718,759

76,023,636

80,288,758

Operating Expenses

Selling, General and Administrative Expenses

10,848,029

8,922,627

39,916,518

29,036,962

Professional Services

1,115,457

1,112,975

3,558,501

6,722,554

Loss on Impairment

1,810,890

8,011,405

1,801,740

8,011,405

Salaries

6,561,800

5,292,996

23,883,354

20,990,290

Stock Based Compensation

2,952,669

883,890

3,574,831

2,672,713

Total Operating Expenses

23,288,845

24,223,893

72,734,944

67,433,924

Income from Operations

(16,255,089)

(2,505,134)

3,288,692

12,854,834

Other Income (Expense)

Interest Expense, net

(8,112,391)

(6,827,557)

(32,069,082)

(30,139,645)

Unrealized Gain (Loss) on Derivative Liabilities

1,384,228

(9,690,200)

15,870,233

18,414,760

Other Loss

68,400

3,736

68,400

24,136

Loss on Business Disposition

(1,968,807)

(4,684,366)

(1,968,807)

(4,684,366)

Unrealized Gain (Loss) on Investments

3,083

1,816

(39,270)

Total Other Income (Expense)

(8,628,570)

(21,195,304)

(18,097,441)

(16,424,385)

Pre-Tax Net Income (Loss)

(24,883,659)

(23,700,438)

(14,808,749)

(3,569,551)

Provision for Income Taxes

4,494,049

3,638,695

19,740,595

14,898,064

Net Income (Loss)

$

(29,377,708)

$

(27,339,133)

$

(34,549,344)

$

(18,467,615)

Less: Accumulated Preferred Stock Dividends for the Period

(1,541,341)

(2,508,677)

(8,154,993)

(7,802,809)

Net Income (Loss) Attributable to Common Stockholders

$

(30,919,049)

$

(29,847,810)

$

(42,704,337)

$

(26,270,424)

Earnings (Loss) per Share Attributable to Common Stockholders

Basic Earnings (Loss) per Share

$

(0.43)

$

(0.57)

$

(0.66)

$

(0.49)

Diluted Earnings (Loss) per Share

$

(0.43)

$

(0.57)

$

(0.66)

$

(0.49)

Weighted Average Number of Shares Outstanding – Basic

71,680,200

53,637,003

64,535,245

53,637,003

Weighted Average Number of Shares Outstanding – Diluted

71,680,200

53,637,003

64,535,245

53,637,003

Comprehensive Income (Loss)

$

(29,377,708)

$

(27,339,133)

$

(34,549,344)

$

(18,467,615)

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Periods Ended December 31, 2023 and 2022
Expressed in U.S. Dollars

For the Twelve Months Ended

December 31,

2023

2022

(Audited)

(Audited)

Cash Flows from Operating Activities:

Net Income (Loss) for the Period

$

(34,549,344)

$

(18,467,615)

Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities

Depreciation & Amortization

20,933,541

10,660,172

Non-Cash Interest Expense

4,024,604

4,118,391

Impairment of Goodwill

1,801,740

8,011,405

Non-Cash Lease Expense

7,648,531

3,910,679

Deferred Taxes

(2,090,967)

502,070

Loss on Disposition of Business Units

1,968,807

4,684,369

Change in Derivative Liabilities

(15,870,233)

(18,414,760)

Amortization of Debt Issuance Costs

1,686,049

1,686,048

Amortization of Debt Discount

8,523,493

7,484,613

(Gain) Loss on Investments, net

(1,816)

39,270

Stock Based Compensation

3,590,473

812,073

Changes in Operating Assets & Liabilities (net of Acquired Amounts):

Accounts Receivable

927,259

(105,185)

Inventory

4,571,069

789,399

Prepaid Expenses & Other Current Assets

1,579,349

(2,770,179)

Other Assets

263,419

(248,682)

Change in Operating Lease Liabilities

(7,498,128)

(13,113,041)

Accounts Payable & Other Liabilities

(3,241,850)

11,845,245

Income Taxes Payable

17,934,967

5,270,074

Net Cash Provided by (Used in) Operating Activities

12,200,963

6,694,346

Cash Flows from Investing Activities:

Collection of Notes Receivable

11,944

Cash Consideration for Acquisition of Business, net of Cash Acquired

(15,834,378)

(58,981,226)

Purchase of Fixed Assets

(7,865,654)

(14,007,892)

Purchase of Intangible Assets

(2,750,000)

Investment in Private Entity

(2,000,000)

Net Cash Provided by (Used in) Investing Activities

(26,438,088)

(74,989,118)

Cash Flows from Financing Activities:

Payment on Notes Payable

(5,354,218)

(134,498)

Proceeds from Issuance of Common Stock

978,308

Payment for Statutory Withholdings on RSU

(108,978)

Net Cash Provided by (Used in) Financing Activities

(5,463,196)

843,810

Net (Decrease) in Cash & Cash Equivalents

(19,700,321)

(67,450,962)

Cash & Cash Equivalents at Beginning of Period

38,949,253

106,400,216

Cash & Cash Equivalents at End of Period

$

19,248,932

$

38,949,253

Supplemental Disclosure of Cash Flow Information:

Cash Paid for Interest

$

17,896,954

$

15,243,990

Cash Paid for Income Taxes

5,000,000

12,340,000

MEDICINE MAN TECHNOLOGIES, INC.
ADJUSTED EBITDA RECONCILIATION (NON-GAAP)
For the Periods Ended December 31, 2023 and 2022
Expressed in U.S. Dollars

For the Three Months Ended

For the Twelve Months Ended

December 31,

December 31,

2023

2022

2023

2022

Net Income (Loss)

$

(29,364,680)

$

(27,339,133)

$

(34,549,344)

$

(18,467,615)

Interest Expense, net

8,112,391

6,827,557

32,069,082

30,139,645

Provision for Income Taxes

4,494,049

3,638,695

19,740,595

14,898,064

Other (Income) Expense, net of Interest Expense

516,180

14,367,747

(13,971,641)

(13,715,260)

Depreciation & Amortization

3,162,425

3,701,128

18,970,960

12,524,677

Earnings Before Interest, Taxes, Depreciation and

Amortization (EBITDA) (non-GAAP)

$

(13,079,635)

$

1,195,994

$

22,259,652

$

25,379,511

Non-Cash Stock Compensation

1,597,157

883,890

2,219,319

2,672,713

Deal Related Expenses

2,196,733

1,914,820

5,528,048

6,822,111

Capital Raise Related Expenses

1,779

(257,271)

38,559

533,958

Inventory Adjustment to Fair Market Value for

Purchase Accounting

5,792,488

5,792,488

6,541,651

One-Time Inventory Impairment

7,353,972

7,353,972

One-Time Goodwill Impairment

1,801,740

8,011,405

1,801,740

8,011,405

Severance

111,752

263,374

537,584

334,910

Retention Program Expenses

505,655

Employee Relocation Expenses

5,065

(3,750)

70,107

15,360

Pre-Operating & Dark Carry Expenses

2,663,824

1,027,738

2,663,824

1,027,738

One-Time Legal Settlements

1,204,058

440,000

1,204,058

440,000

Other Non-Recurring Items

1,304,501

(191,674)

3,436,773

230,858

Adjusted EBITDA (non-GAAP)

$

10,953,434

$

13,284,526

$

53,411,779

$

52,010,215

Revenue

43,324,815

40,147,287

172,447,786

159,379,219

Adjusted EBITDA Percent

25.3 %

33.1 %

31.0 %

32.6 %

View original content:https://www.prnewswire.co.uk/news-releases/schwazze-announces-fourth-quarter-and-full-year-2023-financial-results-302101678.html

Continue Reading

Cannabis

Hemp, Inc. Announces Significant Progress in Hemp Seed Meal Approval for Laying Hen Diets

Published

on

Continue Reading

Cannabis

Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors

Published

on

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania